Bullish Moving Averages
0
Bearish Moving Averages
16
Back Stocks profile
Stock analysis tool for investors
Performance
Today’s low
7.40Today’s High
7.8052W low
6.6052W High
10.40Open Price
7.80Prev. Close
7.2700Volume
317195.00Value
2378962.50Fundamentals
Market Cap
40.50
Price to Earnings
3.30
Price to Book Value
0.70
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM
40.01
Net Profit TTM
12.31
Cash From Operating Activity
-0.37
Return on Equity %
21.49
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
30 Jul, 2024
69.3
Week
75.2
Month
79.7
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
7.72
PIVOT
First Resistance
7.80
Second Resistance
7.94
Third Resistance
8.02
First Support
7.58
Second Support
7.50
Third Support
7.36
Relative Strength Index
52.02
Money Flow Index
59.22
MACD
-0
MACD Signal
-0
Average True Range
0.34
Average Directional Index
12.15
Rate of Change (21)
2.95
Rate of Change (125)
-19.85
Commodity Channel Index
27.3
Williams %R
-56
BETA
1 Month
0.53
3 Month
0.28
1 Year
0.48
3 Year
0.09
PRICE CHANGE ANALYSIS
↑ 0.67%
1 Week
Low
High
7.36
7.86
↑ 0.54%
1 Month
Low
High
7.11
8.23
↓ -4.59%
3 Months
Low
High
6.9
8.23
↓ -22.06%
6 Months
Low
High
6.9
10.34
↑ 10.15%
1 Year
Low
High
6.55
10.39
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 6.32 | 11.97 | 12.69 | 12.21 | 14.01 | 11.16 | 11.63 | 11.48 | 8.52 | 11.31 | 10.01 | 12.54 | 7.41 | |
| Operating Expenses Qtr | 3.28 | 9.91 | 10.41 | 9.66 | 11.48 | 9.05 | 9.20 | 9.24 | 6.54 | 9.05 | 7.83 | 10.02 | 5.55 | |
| Operating Profit Qtr | 0.97 | 1.49 | 2.01 | 2.27 | 2.20 | 1.97 | 2.16 | 2.01 | 1.94 | 2.11 | 2.15 | 2.41 | 1.84 | |
| EBIDT Qtr Cr | 3.05 | 2.06 | 2.28 | 2.54 | 2.53 | 2.11 | 2.43 | 2.24 | 1.98 | 2.26 | 2.18 | 2.52 | 1.85 | |
| Depreciation Qtr | 0.34 | 0.36 | 0.36 | 0.36 | 0.33 | 0.36 | 0.35 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.35 | |
| Net Profit Qtr | 8.58 | 1.12 | 1.26 | 1.34 | 1.30 | 1.19 | 1.46 | 1.30 | 1.07 | 1.36 | 1.27 | 1.50 | 0.90 | |
| Basic EPS Qtr | 1.59 | 0.21 | 0.23 | 0.25 | 0.04 | 0.37 | 0.45 | 0.41 | 0.33 | 0.42 | 0.40 | 0.47 | 0.28 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 43.19 | 48.28 | 42.38 | 35.37 | 13.26 | |
| Operating Expenses Annual Cr | 33.26 | 38.97 | 33.45 | 27.52 | 11.12 | |
| Operating Profit Annual | 6.75 | 8.33 | 8.61 | 7.83 | 2.13 | |
| Operating Profit Margin Annual % | 15.62 | 17.25 | 20.33 | 22.15 | 16.04 | |
| Total Expenses Annual Cr | 35.06 | 40.86 | 35.31 | 29.72 | 13.22 | |
| EBIDT Annual Cr | 9.94 | 9.31 | 8.93 | 7.85 | 2.14 | |
| EBIDT Annual margin % | 23.00 | 19.29 | 21.07 | 22.20 | 16.16 | |
| Depreciation | 1.42 | 1.41 | 1.44 | 1.42 | 1.28 | |
| PAT Before ExtraOrdinary Items Annual Cr | 12.55 | 5.26 | 5.20 | 4.07 | 0.03 | |
| Net Profit Annual | 12.55 | 5.26 | 5.20 | 4.07 | 0.03 | |
| Basic EPS Annual | 2.32 | 0.16 | 1.62 | 1.27 | 0.01 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 58.37 | 45.81 | 14.24 | 9.07 | 5.01 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 1.51 | 7.81 | 5.62 | 5.97 | 6.77 | |
| Total Current Liabilities Annual Cr | 10.07 | 20.70 | 19.98 | 5.33 | 5.35 | |
| Total Capital Plus Liabilities Annual Cr | 69.96 | 74.32 | 39.84 | 20.38 | 17.13 | |
| Fixed Assets Annual | 6.02 | 7.03 | 6.91 | 8.10 | 9.56 | |
| Total Non Current Assets Annual | 14.47 | 15.76 | 8.13 | 9.30 | 10.76 | |
| Total Current Assets Annual | 55.48 | 58.55 | 31.70 | 11.07 | 6.37 | |
| Total Assets Annual | 69.96 | 74.32 | 39.84 | 20.38 | 17.13 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | -0.37 | -5.26 | 1.68 | 3.90 | -1.29 | |
| Cash from Investing Activity Annual | -0.41 | -1.54 | -0.25 | -0.26 | -2.32 | |
| Cash from Financing Annual Activity | -1.04 | 25.87 | -1.67 | -4.82 | 4.75 | |
| Net Cash Flow Annual | -1.83 | 19.08 | -0.23 | -1.17 | 1.14 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 10.81 | 8.48 | 4.44 | 2.83 | 1.56 | |
| ROE Annual % | 21.49 | 11.47 | 36.50 | 44.90 | 0.56 | |
| ROCE Annual % | 14.21 | 14.74 | 37.71 | 42.77 | 7.35 | |
| Total Debt to Total Equity Annual | 0.06 | 0.09 | 0.30 | 0.61 | 1.90 | |
| EBDIT Annual Margin % | 24.83 | 19.69 | 21.22 | 22.21 | 16.18 |
| Indicator | Graph |
|---|---|
| Total Qtr Revenue cr | |
| Operating Expenses Qtr | |
| Operating Profit Qtr | |
| EBIDT Qtr Cr | |
| Depreciation Qtr | |
| Net Profit Qtr | |
| Basic EPS Qtr |
| Indicator | Graph |
|---|---|
| Total Revenue Annual | |
| Operating Expenses Annual Cr | |
| Operating Profit Annual | |
| Operating Profit Margin Annual % | |
| Total Expenses Annual Cr | |
| EBIDT Annual Cr | |
| EBIDT Annual margin % | |
| Depreciation | |
| PAT Before ExtraOrdinary Items Annual Cr | |
| Net Profit Annual | |
| Basic EPS Annual |
| Indicator | Graph |
|---|---|
| Total ShareHolders Funds Annual | |
| Minority Interest Liability Annual Cr | |
| Total Non Current Liabilities Annual Cr | |
| Total Current Liabilities Annual Cr | |
| Total Capital Plus Liabilities Annual Cr | |
| Fixed Assets Annual | |
| Total Non Current Assets Annual | |
| Total Current Assets Annual | |
| Total Assets Annual | |
| Contingent Liabilities plus Commitments Annual Cr |
| Indicator | Graph |
|---|---|
| Cash from Operating Activity Annual | |
| Cash from Investing Activity Annual | |
| Cash from Financing Annual Activity | |
| Net Cash Flow Annual |
| Indicator | Graph |
|---|---|
| Book Value Per Share Annual | |
| ROE Annual % | |
| ROCE Annual % | |
| Total Debt to Total Equity Annual | |
| EBDIT Annual Margin % |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| GAUTAM MOHAN DESHPANDE | 11.44 | 88804033 | 100 | 0 |
| SOWMYA GAUTAM DESHPANDE | 7.1 | 88804034 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Nov 28, 2022 | 0.05 | INTERIM | Nov 28, 2022 | Equity Share |
| Jul 20, 2022 | 0.1 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| Jul 12, 2024 | To consider issue of Warrants | - |
| May 28, 2024 | Audited Results & Issue of Warrants | - |
| Apr 15, 2024 | To consider Issue of Warrants | - |
| Feb 20, 2024 | To consider issue of Warrants | - |
| Jan 31, 2024 | Quarterly Results | - |
| Oct 27, 2023 | Quarterly Results | - |
| Aug 11, 2023 | Quarterly Results | - |
| May 29, 2023 | Audited Results | - |
| Apr 20, 2023 | Stock Split | Bonus issue : decided not to take this agenda for approval. |
| Feb 13, 2023 | Quarterly Results | - |
| Dec 28, 2022 | Rights issue of Equity Shares | - |
| Nov 14, 2022 | Quarterly Results & Interim Dividend | - |
| Nov 03, 2022 | Rights issue | - |
| Oct 21, 2022 | General Purpose | - |
| Jul 09, 2022 | Quarterly Results & Rights issue | - |
| Jun 29, 2022 | Rights issue & Preferential issue of shares | - |
| May 28, 2022 | Audited Results & Rights issue | - |
| Feb 11, 2022 | Quarterly Results | - |
| Nov 08, 2021 | Quarterly Results & Others | Inter alia, to appoint Dr. Sudhir Kamath (DIN: 01250059) as Non Executive Non Independent Director of the Company; |
| Aug 13, 2021 | Quarterly Results | - |
| Jun 29, 2021 | Audited Results | - |
| Feb 12, 2021 | Quarterly Results | - |
| Nov 12, 2020 | Quarterly Results | - |
| Sep 15, 2020 | Quarterly Results | - |
| Jul 31, 2020 | Audited Results | - |
| Feb 13, 2020 | Quarterly Results | - |
| Nov 14, 2019 | Quarterly Results | - |
| Aug 13, 2019 | Quarterly Results | - |
| May 29, 2019 | Audited Results & A.G.M. | - |
| Feb 13, 2019 | Quarterly Results | - |
| Nov 14, 2018 | Quarterly Results | - |
| May 29, 2018 | Audited Results | - |
| Feb 14, 2018 | Quarterly Results | - |
| Nov 14, 2017 | Quarterly Results | - |
| Aug 11, 2017 | Others | - |
| May 30, 2017 | Audited Results | - |
| May 02, 2017 | Others | - |
| Feb 10, 2017 | Quarterly Results & Others | To consider and approve Shifting of Registered office of the Company within the local limit of the City. |
| Nov 11, 2016 | Quarterly Results | - |
| Aug 13, 2016 | Quarterly Results & Others | To consider and approve the draft Directors Report of the 22nd Annual General Meeting of the Company; |
| May 28, 2016 | Audited Results | - |
| Feb 20, 2016 | Others | 1. To accept the resignation of Ms. Rachana Shridharani as Company Secretary and Compliance Officer. 2. To consider the appointment of Company Secretary and Compliance officer. |
| Feb 09, 2016 | Quarterly Results & Others | To consider the re-appointment of Dr. Gautam Deshpande - Managing Director of the Company. |
| Nov 09, 2015 | Quarterly Results | - |
| Aug 14, 2015 | Audited Results & Others | 1. Appointed Secretarial Auditors for the Financial Year 2015-2016. 2. Accepted the resignation of Ms. Priyanka Mukherjee, Company Secretary & Compliance officer. |
| Jun 17, 2015 | Appointment of Additional Director | To Consider the appointment Dr. Sowmya Gautam Deshpande as Additional Director. |
| May 29, 2015 | Audited Results | - |
| May 11, 2015 | Raising of Funds & Others | 1. To Consider the appointment of Company Secretary and Compliance Officer. 2. To Consider expansion of business and raising of funds from eligible investors to the maximum amount of Rs. 25 crores. |
| Jan 29, 2015 | Quarterly Results & Others | 1. To consider appointment of Independent Director. 2. To consider the resignation of Ms. Kanchan Parab, Company Secretary & Compliance Officer. |
| Dec 25, 2014 | Change of Name of the Company | - |
| Nov 13, 2014 | Quarterly Results | (Revised) |
| May 30, 2014 | To appoint a Company Secretary | To appoint a Company Secretary . |
| Feb 01, 2014 | Quarterly Results & Others | - |
| Oct 29, 2013 | Quarterly Results & Others | To Consider the resignation of Ms. Keenjal Zaveri, Compliance Officer and to appointment a Compliance Officer in her place & resignation of Dr. Sudhirkumar Deshpande, Independent Director. |
| Aug 13, 2013 | Quarterly Results & Audited Results | - |
| Jun 29, 2013 | Quarterly Results | - |
| Apr 12, 2013 | Others | To consider raising of funds through preferential issue of equity shares & alteration of the Main Objects & resignation of existing Auditor & shifting of the registered office. & delisting of shares. |
| Jan 30, 2013 | Quarterly Results | - |
| Jun 28, 2012 | Reduction of Capital & Others | To consider the followings: 1. To send a notice to call Annual General Meeting. 2. To transfer of shares. 3. To regularization of directors of the Company. 4. To consider the scheme of Merger. |
| Feb 10, 2012 | General | The Board has approved the notice convening EGM to be held on March 05, 2012, to approve the change of name & object clause of the Company and also to approve the appointment of new Statutory Auditor. |
| Jan 02, 2012 | To change in name of the Company | Inter alia, to consider to change in name of the Company, to transfer of Shares and to change the Statutory Auditor of the Company. |
| Nov 14, 2011 | Quarterly Results & Others | 1. To take note of the result of the Open Offer made by Anil Babulal Agrawal (the "Acquirer") as per the provisions of SEBI (SAST) Regulations, 1997. 2. Change in Registered Office of the Company. |
| Sep 02, 2002 | Accounts | - |
| Apr 29, 2002 | Quarterly Results | - |
| Mar 14, 2002 | Others | To discuss about the resignation of Statutory Auditors NIRANJAN AGRAWAL & ASSOCIATES and to appoint new Auditors in place of the resigned Auditors. |
| Jan 31, 2002 | Quarterly Results | - |
| Oct 30, 2001 | Quarterly Results | - |
| Jul 27, 2001 | Quarterly Results | - |
| Jun 30, 2001 | Accounts | - |
| Apr 28, 2001 | Quarterly Results | - |
| Feb 24, 2001 | Others | Sale or disposal of office cum factory premises. |
| Jan 23, 2001 | Quarterly Results | - |
| Oct 25, 2000 | Quarterly Results | - |
| Aug 12, 2000 | Accounts | - |
| Jul 28, 2000 | Quarterly Results | - |
| Apr 28, 2000 | Quarterly Results | - |
| Jan 29, 2000 | Quarterly Results | - |
| Dec 15, 1999 | Others | - |
| Oct 30, 1999 | Quarterly Results | - |
| Jul 30, 1999 | Quarterly Results | - |
| Apr 30, 1999 | Quarterly Results | - |
| Jan 29, 1999 | Quarterly Results | - |
| Oct 29, 1998 | Quarterly Results | - |
| May 28, 1998 | Half Yearly Results | - |
| Mar 20, 1998 | Issue of share warrants on Pref. basis | - |
| Aug 09, 1997 | Accounts | - |
| May 24, 1997 | Half Yearly Results. | - |
| Mar 15, 1997 | Review of business. | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
30 Jul 2024
Family Care Hospitals Ltd - 516110 - Disclosure Of The Material Events / Information Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations").
Intimation under Regulation 30 of SEBI (LODR) 2015 in relation to Preferential Issue of Warrants
20 Jul 2024
Family Care Hospitals Ltd - 516110 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Notice published in the newspapers in respect of the Postal Ballot of the Company
12 Jul 2024
Family Care Hospitals Ltd - 516110 - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, 12Th July, 2024, Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")
In furtherance to our intimation dated 5th July, 2024 and pursuant to Regulation 30 of SEBI Listing Regulations, we wish to inform you that the Board of Directors of the Company at their meeting held today i.e. 12th July, 2024, has considered and approved the items as notified in the Outcome attached.
10 Jul 2024
Family Care Hospitals Ltd - 516110 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for the Quarter ended 30th June 2024
05 Jul 2024
Family Care Hospitals Ltd - 516110 - Board Meeting Intimation for Prior Intimation Under Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 As Amended ('SEBI Listing Regulations') - Board Meeting To Be Held On July 12, 2024
Family Care Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/07/2024 ,inter alia, to consider and approve Pursuant to provisions of Regulations 29 of the SEBI Listing Regulations, we wish to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, July 12, 2024, inter alia, to consider and evaluate a proposal for raising of funds, by way of issue of one or more instruments including equity shares, convertible securities of any description and/or warrants, on rights / preferential issue or any other permissible method and/or combination thereof as may be considered appropriate, subject to such regulatory/statutory approvals as may be required.
05 Jul 2024
Family Care Hospitals Ltd - 516110 - Announcement under Regulation 30 (LODR)-Resignation of Director
Intimation of Resignation of Independent Director Mr. Pankaj Samani
29 Jun 2024
Family Care Hospitals Ltd - 516110 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (LODR) Regulations 2015
28 Jun 2024
Family Care Hospitals Ltd - 516110 - Closure of Trading Window
Intimation regarding Closure of Trading Window for the quarter ended 30.06.2024
31 May 2024
Family Care Hospitals Ltd - 516110 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Intimation of Newspaper Publication of Audited Financial Results of Quarter and Year ended 31st March 2024
